An organisation called The Social Medwork is promising to deliver "cutting edge therapies" to Australian patients by sourcing overseas-approved items abroad.
Founded in the US in 2014, The Social Medwork has an "international team of doctors and pharmacists who constantly scan for innovative medicines that have recently been approved somewhere in the world".
"Every year, groundbreaking new therapeutics..receive FDA approval.
"From there it can take an average of two years for such medicines to become available in Australian hospitals and pharmacies."
Currently the group offers 14 treatments, "nine of which are currently directly unattainable to patients in Australian pharmacies".
These include a Japan-approved treatment for motor neurone disease, the latest FDA-approved breast cancer drug and an FDA-approved leukaemia treatment.
"Additional promising treatments are expected to be approved in the US within the next few months...we're going to do our best to ensure that they're accessible to Australians within weeks of their FDA approval," said The Social Medwork's Dr Jan de Witt.
The Social Medwork claims its processes are 100% legal, with the organisation "officially registered as an independent intermediary for medicines with the Ministry of Health in the Netherlands".
Patients can request a quote by emailing details of a doctor's prescription along with a shipping address, which must be a pharmacy in the same country where the patient and doctor are located.
For more information see thesocialmedwork.com.
The above article was sent to subscribers in Pharmacy Daily's issue from 09 Sep 16
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 09 Sep 16
